eCite Digital Repository

Antidiabetic, Antihypertensive and Statin Medication Use in Metabolic Syndrome

Citation

Butkowski, E and Brix, L and Al-Aubaidy, HAM and Kiat, H and Jelinek, HF, Antidiabetic, Antihypertensive and Statin Medication Use in Metabolic Syndrome, International Journal of Pharmaceutical Sciences and Developmental Research, 2, (1) pp. 021-026. (2016) [Refereed Article]


Preview
PDF
2Mb
  

Copyright Statement

Copyright 2016 The Authors Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

Official URL: http://www.peertechz.com/Pharmaceutical-Sciences-D...

Abstract

Background: Metabolic syndrome (MetS) is characterised by a cluster of metabolic risk factors, which eventually increases the risk of diabetes and cardiovascular disease (CVD). The aim of the current study was to investigate medication use in outpatient communities with respect to the occurrence of these metabolic risk factors as defined by ATPIII.

Methods: Data for this study was obtained from patients attending a diabetes health screening clinic (DiabHealth) in south-eastern Australia between 2005 and 2011. Participants had a medical history taken and anthropomorphic data collected. Participants with three or more MetS factors were classified as MetS positive as outlined by the National Cholesterol Education Program Adult Treatment Panel III (ATP III).

Results: Antidiabetic, antihypertensive and antihyperlipidaemic use varies significantly in uptake by participants and with respect to the number of ATPIII factors present. Blood glucose levels (BGL) and the female waist circumference were significantly better in the MetS compared to the non-MetS group. The most increase in medication use in the MetS group was seen for antidiabetic medication (21.3% versus 2.4%, p < 0.01) compared to the non-MetS group. Antihypertensive use tripled (67.8% vs. 26.03%) and Statin use doubled significantly (p<0.01) in the MetS group (21.8% vs. 8.9%).

Conclusion: Medication use increases with an increase in ATPIII factors present in the study. Participants with increased BGL (>6.1mmol/L) were not found to have antihyperglycemic medication prescribed. However both antihypertensive medication and Statins were extensively prescribed in cases where only 1 and 2 ATP factors for MetS were present.

Item Details

Item Type:Refereed Article
Keywords:Antihypertensive; Antidiabetic; statin; metabolic syndrome
Research Division:Medical and Health Sciences
Research Group:Medical Biochemistry and Metabolomics
Research Field:Medical Biochemistry: Carbohydrates
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Diabetes
Author:Al-Aubaidy, HAM (Dr Hayder Al-Aubaidy)
ID Code:109572
Year Published:2016
Deposited By:Medicine (Discipline)
Deposited On:2016-06-22
Last Modified:2017-02-10
Downloads:47 View Download Statistics

Repository Staff Only: item control page